PUBLISHER: DelveInsight | PRODUCT CODE: 2167699
PUBLISHER: DelveInsight | PRODUCT CODE: 2167699
Capnography Devices Market Summary
Capnography devices measure and display the concentration of carbon dioxide in exhaled breath, providing a continuous waveform and the end-tidal carbon dioxide value to monitor ventilation, confirm airway placement, and detect respiratory compromise. The category spans handheld capnometers, standalone capnographs, and multiparameter and integrated capnography monitors, and uses sidestream, mainstream, and microstream sampling technologies. Capnography is used across respiratory monitoring, procedural sedation, cardiac and emergency care, trauma, and ventilation, in hospitals, ambulatory surgical centers, emergency medical services, and other settings. These devices are supplied by leading patient monitoring companies including Medtronic, which holds the widely used Microstream technology and Capnostream and Nellcor portfolios, Masimo, Philips, GE HealthCare, Nihon Kohden, and Drager, along with Nonin, ICU Medical, Baxter, and Hamilton Medical. Over the past decade, capnography has become a standard of care for patient safety monitoring during anesthesia, procedural sedation, and resuscitation, supported by guidelines and standards from anesthesia and resuscitation bodies, and has expanded beyond the operating room into procedural, emergency, and general-care settings. Driven by the emphasis on patient safety, the growth of sedation and ventilation, and expanding monitoring standards, capnography devices are an important and steadily growing segment of the patient monitoring market.
Capnography Devices Market Key Growth Drivers
Key Companies in Capnography Devices Market
The competitive landscape is led by the following active developers and manufacturers of capnography devices:
Factors Contributing to the Growth of the Capnography Devices Market
Market Drivers
Capnography as a Standard of Care for Patient Safety
The establishment of capnography as a standard of care for patient safety monitoring is the foundational driver of the capnography devices market. Capnography provides continuous, real-time confirmation of ventilation and early detection of respiratory compromise, airway misplacement, and apnea, and it has become essential for monitoring patients during general anesthesia, procedural sedation, and cardiopulmonary resuscitation. Anesthesia and patient safety bodies have long required capnography during anesthesia, and its use is expanding into procedural sedation and other settings where respiratory depression is a risk. The strong patient safety rationale, supported by evidence that capnography improves the early detection of adverse respiratory events, drives broad adoption. As capnography continues to be recognized and required as a standard of care for patient safety, demand for capnography devices continues to grow, reinforcing sustained market growth throughout the forecast period.
Growing Volume of Sedation, Surgery, and Ventilation
The growing volume of surgical procedures, procedural sedation, and mechanical ventilation is a powerful driver of the capnography devices market. The rising number of surgeries, endoscopic and other procedures performed under sedation, and patients requiring mechanical ventilation, driven by aging populations, rising disease burden, and expanding access to care, increases the use of capnography to monitor ventilation and patient safety. Procedural sedation outside the operating room, including in endoscopy, dentistry, and emergency settings, is a growing area where capnography is increasingly used to detect respiratory depression. The growth of these procedures directly increases capnography utilization and demand for devices and consumables. As procedure, sedation, and ventilation volumes continue to rise, this trend is expected to be a leading driver of capnography device demand across the forecast period.
Market Restraints
Despite steady momentum, the Capnography Devices market faces material constraints. The relatively modest cost of capnography modules and consumables, while supporting adoption, limits the absolute size of the market compared with larger monitoring segments, and capnography is often integrated into multiparameter monitors rather than sold as standalone high-value devices. Gaps in awareness, training, and adoption persist in some settings, particularly for procedural sedation outside anesthesia and in lower-resource environments, where capnography is not yet routinely used despite guideline recommendations. Reimbursement does not directly cover capnography monitoring, which is a facility and procedural cost, and budget constraints can limit adoption of standalone devices. Technical limitations, including sampling artifact, response time, and the need for proper use and interpretation, require training and can affect clinical confidence. Competition and commoditization of capnography modules, and the integration of the function into broader monitors, pressure standalone device pricing. A shortage of trained personnel and variability in monitoring practice can constrain adoption. Rigorous and evolving regulatory requirements for monitoring devices, including Food and Drug Administration pathways and the European Medical Device Regulation, add cost and complexity. Finally, uneven monitoring infrastructure and affordability constraints in emerging markets can restrict adoption across parts of the forecast period, even as these markets offer growth potential.
Capnography Devices Market Segment Analysis
The Capnography Devices Market is segmented by product type (multiparameter and integrated capnography monitors, standalone capnographs, handheld capnometers), technology (sidestream, mainstream, microstream), application (respiratory monitoring, procedural sedation, cardiac care, trauma and emergency care, others), end-user (hospitals, ambulatory surgical centers, others), and geography (North America, Europe, Asia-Pacific, Rest of World).
By Product Type
Dominant Subsegment: Multiparameter and Integrated Capnography Monitors.
The multiparameter and integrated capnography monitors segment accounted for 48% of the Capnography Devices market in 2025. Multiparameter and integrated capnography monitors dominate because capnography is most commonly delivered as a module integrated into multiparameter patient monitors used in operating rooms, intensive care units, and other settings, alongside other vital-sign monitoring. The integration of capnography into the patient monitors from Medtronic, Masimo, Philips, GE HealthCare, Nihon Kohden, and Drager, which are ubiquitous in hospitals, drives the largest share of capnography use. Standalone capnographs, dedicated devices for end-tidal carbon dioxide monitoring, represent an important segment used in specific settings and for procedural sedation, and handheld capnometers represent a growing segment used in emergency, transport, and point-of-care settings where portability is essential. Nonetheless, the prevalence of capnography as an integrated function within the large installed base of multiparameter monitors secures the leadership of this segment across the forecast period, with handheld and portable devices growing in emergency and procedural settings.
By Technology
Dominant Subsegment: Sidestream.
The sidestream segment accounted for 42% of the Capnography Devices market in 2025. Sidestream capnography dominates because it is a versatile and widely used technology that aspirates a sample of exhaled gas through tubing to a sensor within the monitor, enabling use in both intubated and non-intubated patients, including via nasal cannula sampling, across a broad range of settings. Its flexibility, suitability for non-intubated and procedural sedation monitoring, and broad integration into monitors drive the largest share of the market. Mainstream capnography, which measures carbon dioxide directly in the breathing circuit using an airway sensor, offers fast response and is widely used in intubated and ventilated patients, and holds a significant share, particularly in the operating room and critical care. Microstream capnography, which uses very low sample flow and is well suited to non-intubated, pediatric, and procedural sedation monitoring, is a distinct and growing technology led by Medtronic. Nonetheless, the versatility and broad applicability of sidestream capnography across intubated and non-intubated patients secure the leadership of this segment across the forecast period, with mainstream strong in ventilated patients and microstream growing in procedural settings.
Capnography Devices Market Region Analysis
North America accounted for 40% of the global Capnography Devices market revenue in 2025, representing the highest regional market share globally. The region's dominance reflects advanced patient monitoring infrastructure, high procedure and sedation volumes, strong adoption of capnography driven by patient safety standards, and the presence of leading manufacturers. The United States leads on the strength of established requirements and guidelines for capnography during anesthesia and procedural sedation, high adoption across operating rooms, procedural areas, emergency care, and general wards, and the presence of major players including Medtronic, Masimo, and GE HealthCare. The strong patient safety culture and the expansion of capnography into procedural sedation and general care reinforce adoption. The regulatory environment is well established, with the Food and Drug Administration overseeing monitoring devices. Strong monitoring infrastructure and patient safety focus further reinforce the market. This combination of standards, adoption, and manufacturer presence reinforces North America's leadership in the global market.
Fastest Growing Region: Asia-Pacific
Asia-Pacific is the fastest-growing region in the Capnography Devices market. The region's elevated CAGR is driven by large populations, rising surgical and procedure volumes, expanding healthcare and monitoring infrastructure, and growing adoption of patient safety monitoring across China, Japan, India, South Korea, and Southeast Asia. Rising access to surgery, procedural sedation, and critical care, together with growing awareness and adoption of capnography and monitoring standards, expands demand, and growing healthcare investment and the expansion of hospital and emergency infrastructure broaden the installed base. China and India are expanding monitoring capacity and domestic manufacturing, and rising incomes and healthcare development support growth. Both multinational and regional manufacturers, including EDAN, Contec, and others, are expanding their presence. The combination of large populations, rising procedure volumes, expanding infrastructure, and growing adoption of monitoring standards positions Asia-Pacific as the highest-growth region over the forecast period.
Regional Commentary
North America
North America accounted for 40% of the global Capnography Devices market revenue in 2025. The United States dominates the region on the strength of established capnography standards, high procedure and sedation volumes, strong adoption, and the presence of leading manufacturers, while Canada contributes through its healthcare system and Mexico expands access within its growing healthcare sector.
Europe
Europe represents the second-largest regional market, led by Germany, France, and the United Kingdom. Growth is supported by established monitoring standards, high procedure volumes, and the presence of major manufacturers such as Drager and Philips, while the European Medical Device Regulation shapes product requirements and market access across the region.
Asia-Pacific
Asia-Pacific is the fastest-growing region, propelled by large populations, rising surgical and procedure volumes, expanding healthcare and monitoring infrastructure, and growing adoption of patient safety monitoring across China, Japan, India, South Korea, and Southeast Asia. Expanding domestic manufacturing and monitoring capacity are broadening adoption.
Rest of World
The Rest of World region, spanning the Middle East, Africa, and South America, is an emerging growth frontier. Rising surgical and procedure volumes, expanding healthcare and monitoring infrastructure, and growing adoption of patient safety monitoring are broadening demand from a developing base, while investment in monitoring capacity supports growth.
Capnography Devices Market Competitive Landscape
The Capnography Devices market is classified as Consolidated. A group of large patient monitoring companies holds the majority of revenue, led by Medtronic, which holds the widely used Microstream technology, Masimo, Philips, and GE HealthCare, with Nihon Kohden and Drager holding significant positions, while Nonin, ICU Medical, Baxter, Hamilton Medical, and regional manufacturers compete across the market.
The competitive landscape can be evaluated across the following dimensions:
Capnography Devices Market Recent Developmental Activities
In 2023 and 2024, Medtronic continued to advance its Microstream capnography technology and Capnostream and Nellcor portfolios, reinforcing its leadership in capnography. Strategic significance: Sustains Medtronic's leading position in capnography, particularly Microstream technology.
In 2023 and 2024, Masimo expanded its capnography and patient monitoring portfolio, integrating capnography into its monitoring platforms. Strategic significance: Strengthens Masimo's position in integrated capnography and patient monitoring.
Capnography Devices Market Segmentation
Capnography Devices Market by Product Type
Capnography Devices Market by Technology
Capnography Devices Market by Application
Capnography Devices Market by End-User
Capnography Devices Market by Geography
Key Takeaways from the Capnography Devices Market Report Study
Target audience who can benefit from this capnography devices market report study
Q1. What is the growth rate of the Capnography Devices market?
The Capnography Devices market is projected to expand at a CAGR of 7.27% during the forecast period of 2026-2034.
Q2. What is the market size of the Capnography Devices market?
The Capnography Devices market is estimated at USD 676 million in 2025 and is projected to reach USD 1,270 million by 2034.
Q3. Which region dominates the Capnography Devices market?
North America dominated the Capnography Devices market with a 40% share of global revenue in 2025, supported by established capnography standards, high procedure and sedation volumes, strong adoption, FDA oversight, and the presence of leading manufacturers. Asia-Pacific is the fastest-growing region over the forecast period.
Q4. What are the key drivers of the Capnography Devices market?
The principal drivers are the establishment of capnography as a standard of care for patient safety; the growing volume of sedation, surgery, and ventilation; expanding guidelines and monitoring standards requiring end-tidal carbon dioxide monitoring; and the expansion of capnography beyond the operating room, reinforced by technological advancement and the aging population and expanding healthcare access.
Q5. Who are the major players in the Capnography Devices market?
The major players include Medtronic plc, Masimo Corporation, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Nihon Kohden Corporation, Dragerwerk AG & Co. KGaA, Nonin Medical, Inc., ICU Medical, Inc., Baxter International Inc., and Hamilton Medical AG, among other active manufacturers profiled in the Competitive Landscape section. Medtronic holds the widely used Microstream capnography technology, and Masimo, Philips, and GE HealthCare integrate capnography across patient monitoring platforms.
For illustrative purposes, only the top 10 companies are listed in the Table of Contents. The report may include analysis and references to additional companies where relevant to the market assessment.